Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of liquid Saizen in adult-onset growth hormone deficiency
2012-004263-47Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of somatropin in adult onset growth hormone deficiency (AGHD), sponsored by Merck KGaA. Started Jan 2013; status: completed.
02
Drugs
somatropin
03
Conditions
adult onset growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on 2012-004263-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004263-47.